IMMUNIB trial (AIO-HEP-0218/ass): A single-arm, phase II study evaluating safety and efficacy of immunotherapy nivolumab in combination with lenvatinib in advanced-stage hepatocellular carcinoma (HCC)

Arndt Vogel; Gabriele Margareta Siegler; Jurgen Siebler; Udo Lindig; Michael Schultheiss; Tobias Mueller; Henry Simon; Christiane Joeckel; Daniel Wilhelm Mueller; Salah-Eddin Al-Batran; Anna Saborowski; Enrico N. De Toni

IMMUNIB trial (AIO-HEP-0218/ass): A single-arm, phase II study evaluating safety and efficacy of immunotherapy nivolumab in combination with lenvatinib in advanced-stage hepatocellular carcinoma (HCC)

Arndt Vogel
, Gabriele Margareta Siegler
, Jurgen Siebler
, Udo Lindig
, Michael Schultheiss
, Tobias Mueller
, Henry Simon
, Christiane Joeckel
, Daniel Wilhelm Mueller
, Salah-Eddin Al-Batran
, Anna Saborowski
, Enrico N. De Toni

Department of Internal Medicine V, Division of Oncology and Hematology

Research output: Contribution to journal › Original Article › peer-review

15 Citations (Web of Science)

Original language	Undefined/Unknown
Journal	Journal of Clinical Oncology
Publication status	Published - 2022

Cite this

Vogel, A., Siegler, G. M., Siebler, J., Lindig, U., Schultheiss, M., Mueller, T., Simon, H., Joeckel, C., Mueller, D. W., Al-Batran, S.-E., Saborowski, A., & De Toni, E. N. (2022). IMMUNIB trial (AIO-HEP-0218/ass): A single-arm, phase II study evaluating safety and efficacy of immunotherapy nivolumab in combination with lenvatinib in advanced-stage hepatocellular carcinoma (HCC). Journal of Clinical Oncology.

@article{5aa75d14c58d4f8ab9817ba9a8a5b5cc,

title = "IMMUNIB trial (AIO-HEP-0218/ass): A single-arm, phase II study evaluating safety and efficacy of immunotherapy nivolumab in combination with lenvatinib in advanced-stage hepatocellular carcinoma (HCC)",

author = "Arndt Vogel and Siegler, \{Gabriele Margareta\} and Jurgen Siebler and Udo Lindig and Michael Schultheiss and Tobias Mueller and Henry Simon and Christiane Joeckel and Mueller, \{Daniel Wilhelm\} and Salah-Eddin Al-Batran and Anna Saborowski and \{De Toni\}, \{Enrico N.\}",

year = "2022",

language = "Undefined/Unknown",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams \& Wilkins ",

}

Vogel, A, Siegler, GM, Siebler, J, Lindig, U, Schultheiss, M, Mueller, T, Simon, H, Joeckel, C, Mueller, DW, Al-Batran, S-E, Saborowski, A & De Toni, EN 2022, 'IMMUNIB trial (AIO-HEP-0218/ass): A single-arm, phase II study evaluating safety and efficacy of immunotherapy nivolumab in combination with lenvatinib in advanced-stage hepatocellular carcinoma (HCC)', Journal of Clinical Oncology.

IMMUNIB trial (AIO-HEP-0218/ass): A single-arm, phase II study evaluating safety and efficacy of immunotherapy nivolumab in combination with lenvatinib in advanced-stage hepatocellular carcinoma (HCC). / Vogel, Arndt; Siegler, Gabriele Margareta; Siebler, Jurgen et al.
In: Journal of Clinical Oncology, 2022.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - IMMUNIB trial (AIO-HEP-0218/ass): A single-arm, phase II study evaluating safety and efficacy of immunotherapy nivolumab in combination with lenvatinib in advanced-stage hepatocellular carcinoma (HCC)

AU - Vogel, Arndt

AU - Siegler, Gabriele Margareta

AU - Siebler, Jurgen

AU - Lindig, Udo

AU - Schultheiss, Michael

AU - Mueller, Tobias

AU - Simon, Henry

AU - Joeckel, Christiane

AU - Mueller, Daniel Wilhelm

AU - Al-Batran, Salah-Eddin

AU - Saborowski, Anna

AU - De Toni, Enrico N.

PY - 2022

Y1 - 2022

UR - https://publons.com/wos-op/publon/55744382/

M3 - Original Article

SN - 0732-183X

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -

IMMUNIB trial (AIO-HEP-0218/ass): A single-arm, phase II study evaluating safety and efficacy of immunotherapy nivolumab in combination with lenvatinib in advanced-stage hepatocellular carcinoma (HCC)

Other files and links

Cite this